ABcomm, Inc., with headquarters in Champaign, Illinois and Scottsdale, Arizona, has been involved in developing continuing education and training programs for health professionals since 1988.
Our primary focus is on accredited activities for physicians, pharmacists and nurse practitioners. ABcomm, Inc. is accredited by the American Council for Continuing Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Academy of Nurse Practitioners (AANP).
Illustrating Current Perspective in Epilepsy Management
October 7th, 2008
This dinner education session is designed to provide physicians with evidence-based information on current trends in the diagnosis and management of epilepsy. Additionally, it will compare and contrast antiepileptic drugs, both generic and branded, considering pharmacokinetic properties, side-effect profiles, dosing considerations, and therapeutic and biologic equivalence.
Location:
Morton’s The Steakhouse
Course Directors/Instructors:
Jerzy P. Szaflarski, MD, PhD
Associate Professor of Neurology and Neurosciences
University of Cincinnati Academic Health Center
Cincinnati, OH
Cost: Free
Number of credits:
1 AMA PRA Category 1
Credit(s)™
Registration:
By Fax: Fax
completed form to ABcomm at (217) 355 – 1469
On Line: Go
to RSVP website at http://rsvp.abcomminc.com
and enter program code: AAEG5S
By Phone:
Call ABcomm at (800) 451 - 4068
Detailed Description:
This dinner education session is designed to provide physicians with evidence-based information on current trends in the diagnosis and management of epilepsy. Additionally, it will compare and contrast antiepileptic drugs, both generic and branded, considering pharmacokinetic properties, side-effect profiles, dosing considerations, and therapeutic and biologic equivalence.
Learning Objectives:- Discuss current trends in the diagnosis and management of epilepsy based on patient types, seizure etiology and common physical and psychiatric co-morbidities.
- Compare and contrast antiepileptic drugs, both generic and branded, considering pharmacokinetic properties, side-effect profiles, dosing considerations, and therapeutic and biologic equivalence.
- Utilize current treatment guidelines to formulate strategies for seizure management in adults and children, specifically focusing on special populations such as refractory patients, older adults and children with intellectual and developmental disabilities.